Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Dec 7, 2008; 14(45): 6915-6923
Published online Dec 7, 2008. doi: 10.3748/wjg.14.6915
Published online Dec 7, 2008. doi: 10.3748/wjg.14.6915
Transgene | Promoter | Mouse strain | Percentage HCCs | Reference |
c-myc | Alb | C57BL/6 × CBA/J | 65% in males at 20 mo | 40 |
TGF-α | MT | CD1 | 50% in males > 12 mo | 77, 78 |
c-myc/TGF-α | Alb, MT | C57BL/6 × CBA/J × CD1 | 100% in males at 8 mo | 40 |
SV40 T-Ag | ATIII | C57BL/6 × DBA2 | 100% at 8 mo | 36 |
E2F-1 | Alb | C57BL/6 × CBA/J | 33%-60% at 12 mo | 79, 80 |
c-myc/E2F-1 | Alb | C57BL/6 × CBA/J | 100% at 9 mo | 80 |
- Citation: Leenders MW, Nijkamp MW, Rinkes IHB. Mouse models in liver cancer research: A review of current literature. World J Gastroenterol 2008; 14(45): 6915-6923
- URL: https://www.wjgnet.com/1007-9327/full/v14/i45/6915.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.6915